In Vivo Animal

Rodent Disease Models Non-Rodent Disease Models Therapeutic Efficacy Assessment Simulates human disease pathways using validated preclinical models to evaluate therapeutic

Pharmacokinetic (PK) Profiling Bioavailability & Exposure Studies Assesses how a compound is absorbed, distributed, metabolised, and eliminated, generating essential exposure

Maximum Tolerated Dose (MTD) Determination Dose Range Finding (DRF) Studies Defines safe and biologically relevant dose levels by mapping tolerability,

Acute Toxicity Studies Sub-Acute Toxicity Studies Sub-Chronic Toxicity Studies Chronic Toxicity Studies Repeated Dose Toxicity Assessments Evaluates the potential adverse